Barbara W. Bodem insider trades

Open-market stock purchases and sales by Barbara W. Bodem, Director at Biomarin Pharmaceutical Inc, from SEC Form 4 filings since Aug 18, 2017.

Recent trades

DateStockTradeValue
Jun 2, 2026BMRN Biomarin Pharmaceutical IncBought (not open market)—
May 20, 2026OPCH Option Care Health, IncBought (not open market)—
May 19, 2026ENOV Enovis CorpBought (not open market)—

Companies traded

  • BMRN Biomarin Pharmaceutical Inc: other filings, last Jun 2, 2026
  • OPCH Option Care Health, Inc: other filings, last May 20, 2026
  • ENOV Enovis Corp: other filings, last May 19, 2026
  • SYNH Syneos Health, Inc: other filings, last Sep 28, 2023
  • TPTX Turning Point Therapeutics, Inc: other filings, last Aug 17, 2022
  • HRC Hill-Rom Holdings, Inc: other filings, last Dec 13, 2021
  • IVC Invacare Corp: other filings, last Mar 16, 2018

Get free alerts when Barbara W. Bodem files a new trade →